High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

The purpose of this retrospective study was to compare the efficacy and toxicity of high‐dose methotrexate plus temozolomide (MT regimen) and rituximab plus MT (RMT regimen) in patients with untreated primary central nervous system lymphoma (PCNSL). A total of 62 patients with untreated PCNSL were e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cui, Sun, Peng, Cui, Juan, Yan, Shumei, Chen, Hao, Xia, Yi, Bi, Xiwen, Liu, Panpan, Wang, Yu, Yang, Hang, Nie, Man, Zhang, Xue‐Wen, Jiang, Wenqi, Li, Zhi‐Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488123/
https://www.ncbi.nlm.nih.gov/pubmed/30821418
http://dx.doi.org/10.1002/cam4.1906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488123/
https://www.ncbi.nlm.nih.gov/pubmed/30821418
http://dx.doi.org/10.1002/cam4.1906

Ejemplares similares